DANIEL JANNEY

CIK 1198325 · last filed 2026-03-03

DANIEL JANNEY is a corporate insider who has filed 80 SEC Form 4 insider transactions across 11 companies since 2007. The most recent filing shows the insider sold $3.3M of KRYS on Mar 3, 2026. Across all open-market trades the lifetime net is −$107.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $30.1M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$30.11M

Companies

11

Total Filings

80

Lifetime Open-Market Net

-$107.45M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
KRYS Director 74,036 $341.12 $25.26M -$42.01M 16 2026-03-03
Allakos Inc. (ALLK) Delisted Director 6,448,053 $0.33 $2.12M $1.22M 11 2023-05-30
ESPR Director 48,014 $3.18 $152.7K -$2.73M 11 2021-05-28
STRO Director 194,490 $24.17 $4.70M $0 3 2019-06-19
VIVEVE MEDICAL, INC. (VIVE) Delisted Director 1,443 $0.00 $0 $3.00M 16 2019-01-02
VIVEVE MEDICAL, INC. (TCON) Delisted Director 27,278 $0.03 $878 $1.60M 4 2016-01-29
Evofem Biosciences, Inc. (NEOT) Delisted Director 264,963 -$6.01M 2 2015-12-30
ZS Pharma, Inc. (ZSPH) Delisted 10%+ Owner 2,646,643 -$50.75M 1 2015-06-09
ELLIE MAE INC (ELLI) Delisted 10%+ Owner 3,364,708 -$11.77M 1 2011-04-21
ANESIVA, INC. (ANSV) Delisted Director 6,172,840 $0 3 2008-05-12
COTHERIX INC (CTRX) Delisted Director $0 1 2007-01-05

Recent Filings

80 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-03-03 KRYS Sell (S) −11,803 -$3.25M EDGAR
2026-02-27 KRYS Notice (144) −11,803 -$3.25M EDGAR
2026-02-26 KRYS Mixed −22,266 -$16.06M EDGAR
2026-02-26 KRYS Notice (144) −7,741 -$2.13M EDGAR
2026-02-25 KRYS Notice (144) −700 -$192.5K EDGAR
2026-02-24 KRYS Notice (144) −37,895 -$10.11M EDGAR
2026-02-24 KRYS Notice (144) −13,825 -$3.71M EDGAR
2025-06-30 KRYS Grant (A) $0 EDGAR
2024-07-01 KRYS Grant (A) $0 EDGAR
2023-07-03 KRYS Grant (A) $0 EDGAR
Showing 110 of 80
Page 1 of 8
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.